We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Show more
Aditxt, Inc. (โAditxtโ or the โCompanyโ) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced the appointment of Sylvia Hermina to...
Aditxt, Inc. (NASDAQ: ADTX) (โAditxtโ or the โCompanyโ), a social innovation platform dedicated to accelerating promising health innovations, today announced the achievement of a key milestone...
Event to Focus on the Status of the Acquisition, Plans Post-Acquisition for Evofem, and Q&A Aditxt, Inc. (โAditxtโ or the โCompanyโ) (NASDAQ: ADTX), a social innovation platform dedicated to...
Appili has a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets, and subject to the renewal of certain...
Aditxt, Inc. (โAditxtโ โCompanyโ) (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A session with...
Aditxt, Inc. (โAditxtโ ) (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising health innovations, and Evofem Biosciences, Inc. (โEvofemโ) (OTCQB: EVFM), a pioneer in women's...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.4504 | -43.1004784689 | 1.045 | 1.07 | 0.5807 | 2120994 | 0.85782773 | CS |
4 | -4.0454 | -87.1853448276 | 4.64 | 5.12 | 0.5807 | 7562861 | 2.20300881 | CS |
12 | -36.2054 | -98.3842391304 | 36.8 | 85.6 | 0.5807 | 5358595 | 21.19311513 | CS |
26 | -95.0054 | -99.3780334728 | 95.6 | 108 | 0.5807 | 2771106 | 27.85771402 | CS |
52 | -298.6054 | -99.8012700535 | 299.2 | 380 | 0.5807 | 1816627 | 70.8697483 | CS |
156 | -2559.4054 | -99.9767734375 | 2560 | 45584 | 0.5807 | 2205128 | 1130.69990743 | CS |
260 | -8447.4054 | -99.9929616477 | 8448 | 45584 | 0.5807 | 2273033 | 2499.1688177 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions